show episodes
 
R
RAVE: Rheumatoid Arthritis Vital Education
 
Dr. Clifton Bingham from the Johns Hopkins Arthritis Center begins with a review of current best practices, including the issues related to diagnosis. Dr. George Lawry will follow with an overview of the risks and benefits of biologic therapy for patients with RA before Dr. Bingham presents on emerging DMARDs.The second half of the nearly 2 hour presentation covers the subject of comorbidities, presented by Dr. Lawry, on how to recognize comorbidities and how to best manage them. Dr. Bingham ...
 
Loading …
show series
 
N
Neurology® Podcast
 
Show description/summary: 1) Infliximab for the treatment of central nervous system sarcoidosis: A multi-institutional series 2) What’s Trending: Sonic traumatic brain injury This podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the November 14, 2017 issue of Neurology. In the first ...…
 
iTunes | Stitcher I’ve had the pleasure of knowing Ryan for around 3 years now after being introduced through network marketing and then worked on our own start-up together. Ryan works in disability care during the day, and is a rapid learner and investor by night. Ryan reads 100 books per year, regularly practices meditation, has one of the be ...…
 
T
The Therapycast from LCCH International
 
In this episode, depression, inflammation, sleep and mindfulness all come under the spotlight.The sleep research:Westermann J, Lange T, Textor J and Born J (2015) System consolidation during sleep - a common principle underlying psychological and immunological memory formation Trends in Neurosciences 38(10): 585-597Cordi MJ, Schlarb AA and Rasc ...…
 
A study in the March 2015 issue of CGH finds that withdrawal of immunomodulators after at least 6 months of co-treatment with infliximab does not reduce the trough levels of infliximab in patients with Crohn's disease.By cghpodcast@gastro.org (AGA).
 
An article and accompanying editorial in the September issue of CGH discuss reinitiating infliximab therapy for inflammatory bowel disease patients after a period of discontinuation. Dr. Kuemmerle speaks w/ editorial co-author Dr. Maria T. Abreu.By cghpodcast@gastro.org (CGH).
 
A study in the June issue of CGH looks at whether a test-based or empiric dose-escalation strategy is more cost-effective for treating Crohn's disease patients who have stopped responding to Infliximab. Dr. Kuemmerle speaks to Dr. Fernando S. Velayos.By cghpodcast@gastro.org (AGA).
 
Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped. Dr. Kuemmerle speaks to the first author of this study in the January issue of Gastroenterology, Prof. Edouard Louis.By gastropodcast@gastro.org (AGA).
 
A study in the October 2009 Gastroenterology compares colectomy rates following treatment of ulcerative colitis with placebo or infliximabBy gastropodcast@gastro.org (AGA).
 
(June 4, 2009 - Insidermedicine) From Cleveland - According to research in the Cleveland Clinic Journal of Medicine, cases of cubital tunnel syndrome, or "cell phone elbow", are on the rise. The syndrome often occurs after prolonged cell phone use, and manifests as tingling, aching, burning or numbness in the forearm and hand. It can often be t ...…
 
(June 4, 2009 - Insidermedicine) From Cleveland - According to research in the Cleveland Clinic Journal of Medicine, cases of cubital tunnel syndrome, or "cell phone elbow", are on the rise. The syndrome often occurs after prolonged cell phone use, and manifests as tingling, aching, burning or numbness in the forearm and hand. It can often be t ...…
 
February 2009By gastropodcast@gastro.org (AGA Institute).
 
(October 9, 2008 - Insidermedicine) From Munich - According to research from the Cochrane Collaboration, St. John's Wort can effectively treat symptoms of major depression. In a review of 29 studies that included nearly 5,500 participants with major depression, researchers found that those who took St. John's Wort experienced results that were ...…
 
(October 9, 2008 - Insidermedicine) From Munich - According to research from the Cochrane Collaboration, St. John's Wort can effectively treat symptoms of major depression. In a review of 29 studies that included nearly 5,500 participants with major depression, researchers found that those who took St. John's Wort experienced results that were ...…
 
Professor Smolen discusses the evidence supporting the ability of TNF-alpha agents to result in substantial and sustained improvement in symptoms of psoriatic arthritis. Agents including infliximab and etanercept result in not only clinical improvement but also slow the radiographic progression of joint disease and damage. Further, the combinat ...…
 
J
JointHealth™ podcast - Evidenced Based Information on Arthritis
 
Topics discussed with Dr. Shojania include: The challenge of getting diagnosed; The impact of the diagnosis; Accepting one's diagnosis; Learning about one's treatment options; The basics about non-steroidal anti-inflammatory medications (NSAIDs) - when do they get used and why, what do they not do; The basics about disease modifying anti-rheuma ...…
 
Speed
Series preference
1x
1x
Volume
100%
/

Google login Twitter login Classic login